FierceBiotech

An FDA review of records found that results have not [...]

Kailera is taking another step into the competitive obesity market [...]

Spyre Therapeutics’ monoclonal antibody hit the key goal in a [...]

The second time is not the charm for Replimune’s melanoma [...]

Oricell Therapeutics has now raised over $110 million in its [...]

When Fierce last caught up with GSK’s head of oncology [...]

The Orano group has selected a new leader for its [...]

Gilead has tucked another drug candidate into a pipeline bulging [...]

Avalyn Pharma is eyeing an IPO as the biotech seeks [...]

Roche has joined Big Pharma peers in the emerging degrader-antibody [...]